SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (940)3/11/2002 5:38:08 PM
From: Icebrg  Read Replies (1) of 3044
 
>>WASHINGTON -(Dow Jones)- Millennium Pharmaceuticals (NasdaqNM: MLNM - news) Inc. (MLNM) director Ernest Mario purchased 50,000 shares>>

That is a nice story. He bought shares for about a million dollar from the market. Instead of waiting for his options. So, who is the guy and does he know what he is doing? Judging from the information at Millennium's website my guess is that he knows quite a lot.

Ernest Mario, Ph.D., Co-Chairman and Chief Executive Officer of ALZA Corporation

Dr. Mario, Ph.D. has served as a director of COR Therapeutics, Inc. since September 1995. He served as co-chairman and chief executive officer of ALZA Corporation from July 1993 to November 1997 at which time he was appointed chairman and chief executive officer of ALZA. From 1989 to 1993, Dr. Mario was deputy chairman and chief executive officer of Glaxo Holdings plc, a pharmaceutical company, in London. Prior to 1989, he served as chief executive officer of Glaxo, Inc., a pharmaceutical company, in the United States. Dr. Mario is also a director of Catalytica Energy Systems, Inc., Cepheid, Inc., Orchid Biosciences, Inc., Pharmaceutical Product Development, Inc., and SonoSite, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext